Literature DB >> 24958821

Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI.

Christiane K Kuhl1, Simone Schrading2, Kevin Strobel2, Hans H Schild2, Ralf-Dieter Hilgers2, Heribert B Bieling2.   

Abstract

PURPOSE: We investigated whether an abbreviated protocol (AP), consisting of only one pre- and one postcontrast acquisition and their derived images (first postcontrast subtracted [FAST] and maximum-intensity projection [MIP] images), was suitable for breast magnetic resonance imaging (MRI) screening.
METHODS: We conducted a prospective observational reader study in 443 women at mildly to moderately increased risk who underwent 606 screening MRIs. Eligible women had normal or benign digital mammograms and, for those with heterogeneously dense or extremely dense breasts (n = 427), normal or benign ultrasounds. Expert radiologists reviewed the MIP image first to search for significant enhancement and then reviewed the complete AP (consisting of MIP and FAST images and optionally their nonsubtracted source images) to characterize enhancement and establish a diagnosis. Only thereafter was the regular full diagnostic protocol (FDP) analyzed.
RESULTS: MRI acquisition time for FDP was 17 minutes, versus 3 minutes for the AP. Average time to read the single MIP and complete AP was 2.8 and 28 seconds, respectively. Eleven breast cancers (four ductal carcinomas in situ and seven invasive cancers; all T1N0 intermediate or high grade) were diagnosed, for an additional cancer yield of 18.2 per 1,000. MIP readings were positive in 10 (90.9%) of 11 cancers and allowed establishment of the absence of breast cancer, with a negative predictive value (NPV) of 99.8% (418 of 419). Interpretation of the complete AP, as with the FDP, allowed diagnosis of all cancers (11 [100%] of 11). Specificity and positive predictive value (PPV) of AP versus FDP were equivalent (94.3% v 93.9% and 24.4% v 23.4%, respectively).
CONCLUSION: An MRI acquisition time of 3 minutes and an expert radiologist MIP image reading time of 3 seconds are sufficient to establish the absence of breast cancer, with an NPV of 99.8%. With a reading time < 30 seconds for the complete AP, diagnostic accuracy was equivalent to that of the FDP and resulted in an additional cancer yield of 18.2 per 1,000.
© 2014 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2014        PMID: 24958821     DOI: 10.1200/JCO.2013.52.5386

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  117 in total

1.  Utilization of magnetic resonance imaging in breast cancer screening.

Authors:  D Lin; L Moy; D Axelrod; J Smith
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

Review 2.  Novel imaging approaches to screen for breast cancer: Recent advances and future prospects.

Authors:  Christopher L Vaughan
Journal:  Med Eng Phys       Date:  2019-10       Impact factor: 2.242

3.  Three-dimensional MR Fingerprinting for Quantitative Breast Imaging.

Authors:  Yong Chen; Ananya Panda; Shivani Pahwa; Jesse I Hamilton; Sara Dastmalchian; Debra F McGivney; Dan Ma; Joshua Batesole; Nicole Seiberlich; Mark A Griswold; Donna Plecha; Vikas Gulani
Journal:  Radiology       Date:  2018-10-30       Impact factor: 11.105

Review 4.  Applications of Advanced Breast Imaging Modalities.

Authors:  Arwa A Alzaghal; Pamela J DiPiro
Journal:  Curr Oncol Rep       Date:  2018-05-29       Impact factor: 5.075

Review 5.  A review of optical breast imaging: Multi-modality systems for breast cancer diagnosis.

Authors:  Quing Zhu; Steven Poplack
Journal:  Eur J Radiol       Date:  2020-05-18       Impact factor: 3.528

Review 6.  Translating preclinical MRI methods to clinical oncology.

Authors:  David A Hormuth; Anna G Sorace; John Virostko; Richard G Abramson; Zaver M Bhujwalla; Pedro Enriquez-Navas; Robert Gillies; John D Hazle; Ralph P Mason; C Chad Quarles; Jared A Weis; Jennifer G Whisenant; Junzhong Xu; Thomas E Yankeelov
Journal:  J Magn Reson Imaging       Date:  2019-03-29       Impact factor: 4.813

Review 7.  Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.

Authors:  Joy Melnikow; Joshua J Fenton; Evelyn P Whitlock; Diana L Miglioretti; Meghan S Weyrich; Jamie H Thompson; Kunal Shah
Journal:  Ann Intern Med       Date:  2016-01-12       Impact factor: 25.391

8.  Automatic Breast and Fibroglandular Tissue Segmentation in Breast MRI Using Deep Learning by a Fully-Convolutional Residual Neural Network U-Net.

Authors:  Yang Zhang; Jeon-Hor Chen; Kai-Ting Chang; Vivian Youngjean Park; Min Jung Kim; Siwa Chan; Peter Chang; Daniel Chow; Alex Luk; Tiffany Kwong; Min-Ying Su
Journal:  Acad Radiol       Date:  2019-01-31       Impact factor: 3.173

9.  Value of MRI in medicine: More than just another test?

Authors:  Edwin J R van Beek; Christiane Kuhl; Yoshimi Anzai; Patricia Desmond; Richard L Ehman; Qiyong Gong; Garry Gold; Vikas Gulani; Margaret Hall-Craggs; Tim Leiner; C C Tschoyoson Lim; James G Pipe; Scott Reeder; Caroline Reinhold; Marion Smits; Daniel K Sodickson; Clare Tempany; H Alberto Vargas; Meiyun Wang
Journal:  J Magn Reson Imaging       Date:  2018-08-25       Impact factor: 4.813

10.  Independent value of image fusion in unenhanced breast MRI using diffusion-weighted and morphological T2-weighted images for lesion characterization in patients with recently detected BI-RADS 4/5 x-ray mammography findings.

Authors:  Sebastian Bickelhaupt; Jana Tesdorff; Frederik Bernd Laun; Tristan Anselm Kuder; Wolfgang Lederer; Susanne Teiner; Klaus Maier-Hein; Heidi Daniel; Anne Stieber; Stefan Delorme; Heinz-Peter Schlemmer
Journal:  Eur Radiol       Date:  2016-05-18       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.